Singular Health deepens US healthcare foothold with ongoing Triple-S contract talks, PNS licence expansion, and Miami-Dade educational rollout, supported by a solid $10.1 million cash reserve.
- Final-stage discussions with Puerto Rico's Triple-S health plan
- Expansion and renewal talks for PNS contract in the US
- Miami-Dade County Public Schools deployment set for September
- Maintained ISO 27001, HIPAA, SOC 2 compliance; progressing HITRUST
- Strong $10.1 million cash position with nearly two years runway
Triple-S Contract Talks Signal Strategic US Growth
Singular Health Group (ASX:SHG) is closing in on a potentially transformative contract with Triple-S, a leading Puerto Rican health plan. The company is in final-stage negotiations to deploy its 3DICOM platform suite; including diagnostic, patient access, AI, and radiology benefit management tools; across Triple-S’s network. Engagements with the new CEO and senior executives have intensified, underscoring the strategic importance of this opportunity to improve care coordination and reduce duplicate imaging.
Moreover, Triple-S discussions include early enrolment of three of its centres into the existing Provider Network Solutions (PNS) pilot, further integrating Singular Health’s footprint in the region.
PNS Contract Expansion Reflects Growing US Adoption
Singular Health’s partnership with PNS continues to gain momentum. The platform now operates across 750 primary care provider licences, up from 250 last year, following the deployment of 500 additional licences in the previous quarter. PNS has paid the contracted US$500,000 licence fee and reports that the solution is exceeding expectations by improving care coordination and cutting unnecessary imaging.
With the current contract set to expire at the end of Q3 2026, PNS has initiated talks to renew and expand the licence base, mapping out a large-scale rollout strategy. This expansion complements Singular Health’s broader US commercial pipeline, which includes engagement with other major health plans and diagnostic centres.
Educational Deployment and Pilot Programs Advance
Singular Health is preparing for the first student cohort to begin using its 3DICOM EDU platform in Miami-Dade County Public Schools in September 2026. This deployment targets anatomy education and healthcare training in the third largest US school district, with the company viewing it as a scalable model for broader adoption.
The Life Radiology pilot in Florida, leveraging 3DICOM Gateway and Patient solutions to eliminate reliance on physical media, has enrolled over 230 patients in about 15 weeks. Early operational data affirm the platform’s ability to improve patient access and reduce administrative burdens.
Regulatory Compliance and Intellectual Property Progress
Singular Health maintained critical certifications including ISO 27001, HIPAA, and SOC 2 Type II, while advancing toward HITRUST certification; key for engaging large healthcare organisations and payers in the US.
On the intellectual property front, the company progressed national phase patent filings across multiple jurisdictions following a favourable International Preliminary Report on Patentability from WIPO for its Medical File Transfer Protocol technology. This strengthens its global IP position, though patent grants remain subject to national examination.
Financial Position Supports Strategic Execution
The company reported $721,000 in customer receipts for the quarter, including the US$500,000 PNS licence payment, and held a robust cash balance of $10.1 million at quarter-end. This provides nearly two years of runway to execute its US commercial strategy, develop products, and expand market presence.
Operating expenses of $1.71 million reflected increased investment in product development, engineering leadership hires, and commercial activities supporting the growing US pipeline. Additionally, the company received $471,540 in R&D rebates and $795,000 from option exercises, further bolstering liquidity.
Post-Quarter Pilot Expansion with Stellae Health
Shortly after quarter-end, Singular Health signed a non-binding Memorandum of Understanding with Stellae Health, a Florida-based provider within the PNS network, to pilot 3DICOM across primary care practices. This move extends Singular’s market penetration in the PNS ecosystem and tests the platform’s ability to reduce repeat imaging and streamline workflows.
Bottom Line?
Singular Health’s expanding US engagements and solid cash reserves position it well to convert pipeline opportunities into scalable contracts, though key outcomes hinge on finalising agreements with Triple-S and securing funding for statewide projects.
Questions in the middle?
- Will the final contract with Triple-S materialise in the near term and at what scale?
- How will the Florida Statewide Imaging Repository project funding decision impact growth prospects?
- What commercial traction will the Miami-Dade educational deployment generate beyond initial cohorts?